knowledge -WSS

knowledge

author：explore 2025-09-28 19:25:33 - browse：776

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： American taxpayers paid $1.8 trillion in health care costs in 2022

entertainment

WSS

Profiling embryos to choose those with higher IQs is almost a reality

Case highlights the risks of experimental stem cell therapy

Arena BioWorks launches in Cambridge to speed drug discovery

Venture capitalist Bob Kocher on the state of digital health

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Gene therapy denied for Afghan refugee whose father aided U.S.

entertainment

knowledge

leisure time

Drug repurposing or repositioning? The language matters

Profiling embryos to choose those with higher IQs is almost a reality

The cancer drug shortage isn’t new — and neither are the solutions

Gene therapy denied for Afghan refugee whose father aided U.S.

Guidelines to prevent youth baseball injuries need more muscle

NVIDIA and Google execs on the future of AI and drug discovery

Anesthesiologist group: stop taking Ozempic before surgery

Fauci's latest grilling in Congress: 9 hours, behind closed doors

DIEP, the 'gold standard' of breast reconstruction, is under threat

Physician assistants need a new name. Here's what it should be

Wikipedia

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Life science postdocs should get big pay hike, NIH panel says

Life science postdocs should get big pay hike, NIH panel says

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Data integrity in scientific journals requires "effort" by publishers, institutions

In shift, Texas to cover initial consult for Afghan baby's gene therapy

hotspot

entertainment

knowledge

focus